Skip to main content

Pluri Inc.

PLUR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001158780

No open-market purchases or sales by Pluri Inc. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $55.3K in total; no superinvestor holds it.

Q1 2023 vs. Q4 2022

How the institutions holding Pluri Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of PLUR: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders3331−2
Shares695.8K706.5K+10.7K (+1.5%)
Value$652.8K$720.6K+$67.9K (+10.4%)

New holders (6)

Institutions that held Pluri Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to PLUR in Q1 2023
InstitutionSharesValue% of portfolio
Meitav Dash Investments Ltd82,673$85.8K0.00%
Prime Capital Investment Advisors, LLC57,862$59.0K0.00%
EverSource Wealth Advisors, LLC16,000$16.3K0.00%
Kestra Private Wealth Services, LLC10,000$10.2K0.00%
International Assets Investment Management, LLC100$1020.00%
Brown Shipley& Co Ltd330$00.00%

Sold out (8)

Institutions that held Pluri Inc. at the end of Q4 2022 and filed for Q1 2023 without it.

Institutions that sold out of PLUR in Q1 2023
InstitutionShares, Q4 2022Value, Q4 2022
Virtu Financial LLC16,740$16.0K
Citadel Advisors LLC15,323$14.4K
Susquehanna International Group, LLP14,499$13.6K
Two Sigma Securities, LLC14,243$13.4K
Simplex Trading, LLC8,865$8.00K
Activest Wealth Management782$735
Credit Suisse AG139$131
IFP Advisors, Inc150–